Shandong Buchang Pharmaceuticals (603858.SH) announced that its holding subsidiary Zhejiang Tianyuan Biological Pharmaceutical Co., Ltd.'s '...
According to the Zhitong Finance APP, Shandong Buchang Pharmaceuticals (603858.SH) announced that its holding subsidiary Zhejiang Tianyuan Biological Pharmaceutical Co., Ltd.'s application for clinical trial registration of the 'Varicella Live Attenuated Vaccine' has been accepted by the National Medical Products Administration, and a 'Notice of Acceptance' has been received. Indication for the varicella live attenuated vaccine: after vaccination with this vaccine, it can stimulate the body to produce immunity against the varicella-zoster virus. It is used for the prevention of varicella.